Anthera Pharmaceuticals Inc (ANTH)
0.00
USD |
OTCM |
May 06, 16:00
Anthera Pharmaceuticals Cash from Operations (Quarterly): -9.381M for March 31, 2018
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
March 31, 2018 | -9.381M |
December 31, 2017 | -6.26M |
September 30, 2017 | -6.198M |
June 30, 2017 | -10.11M |
March 31, 2017 | -14.33M |
December 31, 2016 | -12.23M |
September 30, 2016 | -14.66M |
June 30, 2016 | -11.33M |
March 31, 2016 | -10.70M |
December 31, 2015 | -9.453M |
September 30, 2015 | -8.702M |
June 30, 2015 | -6.141M |
March 31, 2015 | -6.611M |
December 31, 2014 | -6.236M |
September 30, 2014 | -6.18M |
June 30, 2014 | -7.911M |
March 31, 2014 | -5.274M |
December 31, 2013 | -5.697M |
September 30, 2013 | -6.42M |
Date | Value |
---|---|
June 30, 2013 | -9.157M |
March 31, 2013 | -10.64M |
December 31, 2012 | -15.48M |
September 30, 2012 | -13.76M |
June 30, 2012 | -21.10M |
March 31, 2012 | -23.29M |
December 31, 2011 | -25.96M |
September 30, 2011 | -18.34M |
June 30, 2011 | -18.91M |
March 31, 2011 | -9.854M |
December 31, 2010 | -9.199M |
September 30, 2010 | -7.431M |
June 30, 2010 | -7.644M |
March 31, 2010 | -3.504M |
December 31, 2009 | -6.850M |
September 30, 2009 | -3.718M |
June 30, 2009 | -2.908M |
March 31, 2009 | -3.697M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | -0.314M |
Palatin Technologies Inc | -10.48M |
iBio Inc | -4.706M |
Theriva Biologics Inc | -6.541M |
Oragenics Inc | -1.102M |